Neumora Therapeutics is trading 8.2% down at $1.51 today on profit-taking and liquidity-driven trading following a period of high volatility.
- The move continues a week of sharp price swings for the stock, which has seen several double-digit moves recently.
- There are no new company-specific headlines, earnings reports, or FDA updates tied to the decline.
- Sector peers are generally trading higher, suggesting the move is driven by technical factors rather than a shift in fundamental outlook.